Lisdexamfetamine Dimesylate
NDC 42291-037, Lisdexamfetamine, capsule, from AvKARE.
- Product NDC
- 42291-037
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202830
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/42291-037 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE30 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42291-037-90 | 42291003790 | 90 CAPSULE in 1 BOTTLE (42291-037-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/36c40404-fe94-6fb7-e063-6394a90a2657
Use it
Look up 42291-037 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42291-037 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42291-037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.